Paper41980098
Trem2 exacerbates ischemic brain injury through Gpnmb in a photothrombotic stroke model.
Chen X and 12 others. Proc Natl Acad Sci U S A, 2026. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Trem2 exacerbates ischemic brain injury through Gpnmb in a photothrombotic stroke model. Papers, record 41980098. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41980098
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Membrane Glycoproteins | Major topic |
| Receptors, Immunologic | Major topic |
| Brain Ischemia | Major topic |
| Thrombotic Stroke | Major topic |
| Ischemic Stroke | Major topic |
| Animals | |
| Male | |
| Mice | |
| Microglia | |
| Humans | |
| Disease Models, Animal | |
| Mice, Inbred C57BL | |
| Neurons | |
| Stroke | |
| Eye Proteins |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 32471009 | National Natural Science Foundation of China | PubMed | PubMed | ||
| 32200805 | National Natural Science Foundation of China | PubMed | PubMed | ||
| ZDSYS20220304163558001 | Shenzhen Key Laboratory of Neuroimmunomodulation for Neurological Diseases | ZDSYS202203 | PubMed | NIH RePORTER | |
| JCYJ20220818100803007 | Shenzhen Science and Technology Program | PubMed | PubMed | ||
| JCYJ20210324120804012 | Shenzhen Science and Technology Program | PubMed | PubMed | ||
| RCYX20221008092952129 | Shenzhen Science and Technology Program-The Excellent Youth Scholars | PubMed | PubMed | ||
| 321GJHZ2023248GC | Chinese Academy of Sciences Global Common Challenges Program | PubMed | PubMed | ||
| A2303021 | Shenzhen Medical Academy of Research and Translation | PubMed | PubMed |
References87
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39062850 | Soluble Triggering Receptors Expressed on Myeloid Cells (sTREM) in Acute Ischemic Stroke: A Potential Pathway of sTREM-1 and sTREM-2 Associated with Disease Severity. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39062850 | PubMed |
| 2 | 30523715 | Triggering receptor expressed on myeloid cells-2 expression in the brain is required for maximal phagocytic activity and improved neurological outcomes following experimental stroke. | J Cereb Blood Flow Metab | 2019 | https://conductscience.org/library/papers/30523715 | PubMed |
| 3 | 28186177 | The far-reaching scope of neuroinflammation after traumatic brain injury. | Nat Rev Neurol | 2017 | https://conductscience.org/library/papers/28186177 | PubMed |
| 4 | 15677574 | Motor impairment and recovery in the upper limb after stroke: behavioral and neuroanatomical correlates. | Stroke | 2005 | https://conductscience.org/library/papers/15677574 | PubMed |
| 5 | 29073081 | TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/29073081 | PubMed |
| 6 | 23150934 | TREM2 variants in Alzheimer's disease. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23150934 | PubMed |
| 7 | 35305339 | Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study. | Lancet Neurol | 2022 | https://conductscience.org/library/papers/35305339 | PubMed |
| 8 | 31291966 | Neuroinflammation: friend and foe for ischemic stroke. | J Neuroinflammation | 2019 | https://conductscience.org/library/papers/31291966 | PubMed |
| 9 | 38309272 | Fate mapping of Spp1 expression reveals age-dependent plasticity of disease-associated microglia-like cells after brain injury. | Immunity | 2024 | https://conductscience.org/library/papers/38309272 | PubMed |
| 10 | 39643105 | GPNMB attenuates neuroinflammation and improves ischemic stroke via modulation of PI3K/Akt and p38 MAPK signaling pathways. | Brain Res | 2025 | https://conductscience.org/library/papers/39643105 | PubMed |
| 11 | 35414082 | Soluble TREM2 is associated with death and cardiovascular events after acute ischemic stroke: an observational study from CATIS. | J Neuroinflammation | 2022 | https://conductscience.org/library/papers/35414082 | PubMed |
| 12 | 28856541 | Glycoprotein NMB: an Emerging Role in Neurodegenerative Disease. | Mol Neurobiol | 2018 | https://conductscience.org/library/papers/28856541 | PubMed |
| 13 | 34108545 | Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer. | Sci Rep | 2021 | https://conductscience.org/library/papers/34108545 | PubMed |
| 14 | 24682924 | Induction of matrix metalloproteinase-3 (MMP-3) expression in the microglia by lipopolysaccharide (LPS) via upregulation of glycoprotein nonmetastatic melanoma B (GPNMB) expression. | J Mol Neurosci | 2014 | https://conductscience.org/library/papers/24682924 | PubMed |
| 15 | 30127720 | Microglial TREM2/DAP12 Signaling: A Double-Edged Sword in Neural Diseases. | Front Cell Neurosci | 2018 | https://conductscience.org/library/papers/30127720 | PubMed |
| 16 | 32067825 | Early increment of soluble triggering receptor expressed on myeloid cells 2 in plasma might be a predictor of poor outcome after ischemic stroke. | J Clin Neurosci | 2020 | https://conductscience.org/library/papers/32067825 | PubMed |
| 17 | 38937583 | T cell-mediated microglial activation triggers myelin pathology in a mouse model of amyloidosis. | Nat Neurosci | 2024 | https://conductscience.org/library/papers/38937583 | PubMed |
| 18 | 30232263 | Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/30232263 | PubMed |
| 19 | 30266932 | TREM2 - a key player in microglial biology and Alzheimer disease. | Nat Rev Neurol | 2018 | https://conductscience.org/library/papers/30266932 | PubMed |
| 20 | 36095053 | The role of TREM2 N-glycans in trafficking to the cell surface and signal transduction of TREM2. | J Biochem | 2022 | https://conductscience.org/library/papers/36095053 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42959446 | The microglial lineage: from molecular states to context-dependent functions. | Cell Insight | 2026 | https://conductscience.org/library/papers/42959446 | PubMed |
| 42694654 | TREM2 as a central hub of neuroimmune-metabolic crosstalk in central nervous system disorders: from microglial biology to therapeutic targeting. | Front Immunol | 2026 | https://conductscience.org/library/papers/42694654 | PubMed |
| 42639315 | Microglial immunosurveillance after ischemic stroke: dynamic phenotypes, neurovascular interactions, and therapeutic opportunities. | Front Immunol | 2026 | https://conductscience.org/library/papers/42639315 | PubMed |
| 42630359 | Spatial multi-omics unveils sphingolipid metabolic reprogramming within the retinal pathological niche. | Imeta | 2026 | https://conductscience.org/library/papers/42630359 | PubMed |
| 42443448 | Elamipretide (SS-31) and Nicotinamide Mononucleotide (NMN) Combination Therapy Targets TREM2 to Mitigate Post-ischemic Brain Injury in Mice. | Neurochem Res | 2026 | https://conductscience.org/library/papers/42443448 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GPNMB | 10457 | PubTator's text mining | https://conductscience.org/library/genes/10457 | NCBI Gene |
| TREM2 | 54209 | PubTator's text mining | https://conductscience.org/library/genes/54209 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41980098
GET https://conductscience.org/api/papers/v1/41980098/references?page=2